Skip to main content

Involutional Osteoporosis: Sarcopenia, Frailty Syndrome and Falls

  • Chapter
  • First Online:
Gerontorheumatology
  • 708 Accesses

Abstract

Our society is doomed to struggle against pandemic of civilization diseases. One of the most common of them is osteoporosis. There are several reasons for it, one of the most significant of which is lengthening of human lifespan. In eighteenth century, life expectancy in Europe was 39 years, while two centuries later, it was already 80 years. In 1900, the age median in the USA was 23 years, and a century later, it was already 36 years. Civilization diseases in fact reflect maladaptation to this phenomenon. In connection with the longer life expectancy, the lifestyle of population in advanced countries has dramatically changed – starting from unhealthy dietary habits over to the development of technologies allowing substantial reduction of physical activity in most human activities. Pandemic incidence of involutional osteoporosis and its implications have therefore become in recent decades one of the main healthcare priorities. Although a number of diagnostic (DXA, FRAX) and therapeutic procedures have been developed, we are increasingly aware of the need for a comprehensive approach to what we call “osteoporosis” and its incorporation into the context of the current geriatric medicine [2, 5, 35].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Aspray TJ. New horizons in fracture risk assessment. Age Ageing. 2013;42:548–54.

    Article  PubMed  Google Scholar 

  2. Binkley N, Krueger D, Buehring B. What is in the name revisited: should osteoporosis and sarcopenia be considered components of “dysmobility syndrome”. Osteoporos Int. 2013;24(12):2955–9.

    Google Scholar 

  3. Bischoff-Ferrari HA. Prevention of falls. Primer on the metabolic bone diseases and disorders of mineral metabolism. Am Soc Bone Miner Res. 2013;8:389–95.

    Google Scholar 

  4. Black DM, Rosen CJ. Following the bone density trail: a clinical perspective. J Clin Endocrinol Metab. 2012;97:1176–8.

    Article  CAS  PubMed  Google Scholar 

  5. Cooper C, Dere W, Evans W, et al. Frailty and sarcopenia: definitions and outcome parameters. Osteoporos Int. 2012;23:1839–48.

    Article  CAS  PubMed  Google Scholar 

  6. Cummings SR, Black DM, Newitt MC, et al. Appendicular bone density and age predict hip fracture in women. The Study of Osteoporotic Fractures Research Group. JAMA. 1990;263(5):665–8.

    Article  CAS  PubMed  Google Scholar 

  7. Crilly RG, Kloseck M, Chesworth B, et al. Comparison of hip fracture and osteoporosis medication prescription rates across Canadian provinces. Osteoporos Int. Publ online 02 Aug 2013.

    Google Scholar 

  8. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: european consensus on definition and diagnosis. Age Ageing. 2010;39:412–23.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Dukas L, Bischoff HA, Lindpaintner LS, et al. Alfacalcidol reduces the number of fallers in a community – dwelling elderly population with a minimum calcium intake of more than 500 mg daily. J Am Geriatr Soc. 2004;52:230–6.

    Article  PubMed  Google Scholar 

  10. Dukas L, Schacht E, Mazor T, et al. Treatment with alfacalcidol in elderly people significantly decreases the high risk of falls associated with a low creatinine clearance of bellow 65 ml/min. Osteoporos Int. 2005;16:198–203.

    Article  CAS  PubMed  Google Scholar 

  11. Evans WJ. Skeletal muscle effects on the skeleton. Primer on the metabolic bone diseases and disorders of mineral metabolism. Am Soc Bone Miner Res. 2013;8:978–85.

    Google Scholar 

  12. Fried LP. Frailty. In: Hazzards geriatric medicine and gerontology. New York: McGraw Hill; 2009. p. 631–45.

    Google Scholar 

  13. Fried LP, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med. 2001;56:146–56.

    Article  Google Scholar 

  14. Gast U, Belavy DL, Armbrecht G, et al. Bone density and neuromuscular function in older competitive athletes depend on running distance. Osteoporos Int. 2013;24:2033–42.

    Article  CAS  PubMed  Google Scholar 

  15. Gregson CL, Dennison EM, Compston JE, et al. Disease specific perception of fracture risk and incident fracture rates: GLOW cohort study. Osteoporos Int. 2014;25(1):85–95.

    Article  CAS  PubMed  Google Scholar 

  16. Gojda J. Úbytek svalové hmoty – kachexie vs. sarkopenie: komentovaný překlad. DMEV. 2011;14:97–8.

    Google Scholar 

  17. Guillemin F, Martinez L, Calvert M, et al. Fear of falling, fracture history, and comorbidities are associated with health-related quality of life among European and US women with osteoporosis in a large international study. Osteoporos Int. 2013;24(12):3001–10.

    Article  CAS  PubMed  Google Scholar 

  18. Janssen I, et al. The healthcare costs of sarcopenia in the United States. J Am Geriatr Soc. 2004;52:80–5.

    Article  PubMed  Google Scholar 

  19. Kemmler W, Haberle L, von Stengel S. Effects of exercise on fracture reduction in older adults. Osteoporos Int. 2013;24:1937–50.

    Article  CAS  PubMed  Google Scholar 

  20. Kemmler W, von Stengel S, Bebenek M, et al. Exercise and fractures in postmenopausal women: a 12-year results of the Erlangen Fitness and Osteoporosis Prevention Study (EFOPS). Osteoporos Int. 2012;23:1267–76.

    Article  CAS  PubMed  Google Scholar 

  21. Lang PO, Michel JP, Zekry D. Frailty syndrome: a transitional state in a dynamic process. Gerontology. 2009;55:539–49.

    Article  PubMed  Google Scholar 

  22. Leavy B, Aberg AC, Melhus H, et al. When and where do hip fractures occur? Osteoporos Int. 2013;24:2387–96.

    Article  CAS  PubMed  Google Scholar 

  23. Leslie WD, Lix LM. Comparison between various fracture risk assessment tools. Comparison between various fracture risk assessment tools. Osteoporos Int. 2014;25(1):1–21.

    Article  CAS  PubMed  Google Scholar 

  24. Masud T, Binkley N, Boonen S, et al. Official positions for FRAX clinical regarding falls and frailty: can falls and frailty be used in FRAX? J Clin Densitom. 2011;14:194–204.

    Article  PubMed  Google Scholar 

  25. Morley JE, Kim MJ, Haren MT, et al. Frailty and the ageing male. Ageing Male. 2005;8:135–40.

    Article  CAS  Google Scholar 

  26. Morley JE. Developing novel therapeutic approaches to frailty. Curr Prarm Des. 2009;15:3384–95.

    Article  CAS  Google Scholar 

  27. Richy F, Dukas L, Schacht E. Differential effects of D-hormone analogs and native vitamin D on the risk of falls: a comparative meta-analysis. Calcif Tissue Int. 2008;82:102–7.

    Article  CAS  PubMed  Google Scholar 

  28. Rolland Y, Van Kan GA, Gillete-Guyonnet S, et al. Strontium ranelate and risk of vertebral fractures in frail osteoporotic women. Bone. 2011;48(2):332–8.

    Article  CAS  PubMed  Google Scholar 

  29. Rosen C. Frailty: a D-ficiency syndrome of ageing. J Clin Endocrinol Metab. 2010;95:5210–2.

    Article  CAS  PubMed  Google Scholar 

  30. Runge M, Hunter G. Determinants of musculoskeletal frailty and risk of falls in old age. J Musculoskeletal Neurola Interact. 2006;6:167–73.

    CAS  Google Scholar 

  31. Saltvedt I, Prestmo A, Einarsen E, et al. Development and delivery of patient treatment in the Trondheim Hip Fracture Trial. A new geriatric in-hospital pathway for elderly patients with hip fracture. BMC Res Notes. 2012;5:355.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Schacht E, Ringe JD. Alfacalcidol improves muscle power, muscle function and balance in elderly patients with reduced bone mass. Rheumatol Int. 2012;32(1):207–15.

    Article  CAS  PubMed  Google Scholar 

  33. Schacht E. Reduction of falls and osteoporotic fractures: plain vitamin D or hormone analogs? Geriatr Gerontol Int. 2008;8 Suppl 1:S16–25.

    Google Scholar 

  34. Siris E, et al. Bone mineral density thresholds for pharmacological intervention to prevent fractures. Arch Intern Med. 2004;164:1108–12.

    Article  PubMed  Google Scholar 

  35. Siris ES, Boonen S, Mitchell PJ, et al. What is in the name? What constitutes the clinical diagnosis of osteoporosis? Osteoporos Int. 2012;23:2093–7. 2005;20(10):1813–9. Epub 2005 Jun 20.

    Article  CAS  PubMed  Google Scholar 

  36. Sornay- Rendu E, Munoz F, Garnero P, et al. Identification of osteopenic women at high risk of fracture: the OFELY Study. J Bone Miner Res. 2005;20(10):1813–9. Epub 2005 Jun 20.

    Google Scholar 

  37. Studenski S, Perera S, Patel K, et al. Gait speed and survival rate in older adults. JAMA. 2011;305:50–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Syddall HE, Roberts HC, Evandrou M, et al. Prevalence and correlates of frailty among community – dwelling older men and women: findings from the Hertfordshire Cohort Study. Age Ageing. 2010;39(2):197–203.

    Article  PubMed  Google Scholar 

  39. Syddall HE, Simmonds SJ, Martin HJ, et al. Cohort profile. The Hertfordshire ageing study. Int J Epidemiol. 2010;39:36–43.

    Article  CAS  PubMed  Google Scholar 

  40. Tom SE, Adachi JD, Anderson FA, et al. Frailty and fracture, disability, and falls: a multiple country study from the Global Longitudinal Study of osteoporosis in women. J Am Geriatr Soc. 2013;61:327–34.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Topinkova E. Aging, disability and frailty. Ann Nutr Metab. 2008;52:6–11.

    Article  CAS  PubMed  Google Scholar 

  42. de Vries OJ, Peeters GMEE, Lips P, et al. Does frailty predict increased risk of falls and fractures? Osteoporos Int. 2013;24:2397–404.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jiří Jenšovský .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Jenšovský, J. (2017). Involutional Osteoporosis: Sarcopenia, Frailty Syndrome and Falls. In: Rovenský, J. (eds) Gerontorheumatology. Springer, Cham. https://doi.org/10.1007/978-3-319-31169-2_34

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-31169-2_34

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-31167-8

  • Online ISBN: 978-3-319-31169-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics